Karl Minges, PhD, MPH
Associate Research Scientist in Medicine (Cardiology)DownloadHi-Res Photo
Cards
Appointments
Cardiovascular Medicine
Primary
Contact Info
About
Titles
Associate Research Scientist in Medicine (Cardiology)
Biography
Appointments
Cardiovascular Medicine
Associate Research ScientistPrimary
Other Departments & Organizations
- Cardiovascular Medicine
- Center for Outcomes Research & Evaluation (CORE)
- Internal Medicine
Education & Training
- PhD
- Yale University (2016)
- MPH
- Columbia University (2010)
Research
Overview
Medical Research Interests
Cardiovascular Diseases; Diabetes Mellitus; Health Care Quality, Access, and Evaluation; Socioeconomic Factors
Public Health Interests
Nutrition; Health Equity, Disparities, Social Determinants and Justice; Health Care Management; Health Care Quality, Efficiency; Chronic Diseases
Research at a Glance
Yale Co-Authors
Frequent collaborators of Karl Minges's published research.
Publications Timeline
A big-picture view of Karl Minges's research output by year.
Research Interests
Research topics Karl Minges is interested in exploring.
Jeptha Curtis, MD
Harlan Krumholz, MD, SM
James V. Freeman, MD, MPH, MS
Mayur M. Desai, PhD, MPH, FACE
Sarwat Chaudhry, MD
Alana Rosenberg, MPH
55Publications
2,114Citations
Socioeconomic Factors
Diabetes Mellitus
Publications
2024
Long-Term Outcomes of Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Use Among Patients on Maintenance Dialysis
Pun P, Qin L, Minges K, Al-Khatib S, Friedman D. Long-Term Outcomes of Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Use Among Patients on Maintenance Dialysis. Heart Rhythm 2024 PMID: 39615818, DOI: 10.1016/j.hrthm.2024.11.050.Peer-Reviewed Original ResearchAltmetricConceptsHospital admissionAccess interventionsAssociated with decreased riskFee-for-serviceLongitudinal cohort studyMedicare claims dataAssociated with decreased risk of deathImplantable cardioverter defibrillator useNational Cardiovascular Data Registry ICD RegistryBurden of cardiac diseaseRisk of deathDialysis access interventionsDefibrillator useClaims dataElevated risk of sudden cardiac deathImplantable cardioverter defibrillatorLong-term outcomesRisk of sudden cardiac deathStabilized inverse probabilityDialysis patientsElevated riskInclusion criteriaTV-ICDS-ICDICD RegistryLong-Term Outcomes of Subcutaneous vs. Transvenous Implantable Cardioverter Defibrillator Use among Dialysis Patients
Pun P, Qin L, Minges K, Al-Khatib S, Friedman D. Long-Term Outcomes of Subcutaneous vs. Transvenous Implantable Cardioverter Defibrillator Use among Dialysis Patients. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024zhh3hejt. DOI: 10.1681/asn.2024zhh3hejt.Peer-Reviewed Original ResearchProcedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion
Friedman D, Du C, Zimmerman S, Tan Z, Lin Z, Vemulapalli S, Kosinski A, Piccini J, Pereira L, Minges K, Faridi K, Masoudi F, Curtis J, Freeman J. Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion. Circulation Cardiovascular Interventions 2024, 17: e013466. PMID: 38889251, PMCID: PMC11189610, DOI: 10.1161/circinterventions.123.013466.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsVolume-outcome relationshipLikelihood of procedural successLeft atrial appendage occlusionProcedural successProcedure volumeAppendage occlusionNational Cardiovascular Data Registry LAAO RegistryVolume quartilesLeft atrial appendage occlusion devicesThree-level hierarchical generalized linear modelsMinimum volume thresholdsWatchman FLX deviceProcedural success rateHierarchical generalized linear modelsAssociated with outcomePhysician volumeWATCHMAN procedureFLX deviceOcclusion deviceVolume thresholdCardiovascular proceduresPhysiciansHospitalNational analysisSuccess ratePredicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion
Faridi K, Ong E, Zimmerman S, Varosy P, Friedman D, Hsu J, Kusumoto F, Mortazavi B, Minges K, Pereira L, Lakkireddy D, Koutras C, Denton B, Mobayed J, Curtis J, Freeman J. Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion. Circulation Arrhythmia And Electrophysiology 2024, 17: e012424. PMID: 38390713, PMCID: PMC11021146, DOI: 10.1161/circep.123.012424.Peer-Reviewed Original ResearchCitationsAltmetricConceptsNational Cardiovascular Data RegistryLeft atrial appendage occlusionIn-hospital major adverse eventsMajor adverse eventsBedside risk scoreRisk scoreData RegistryIncreased fall riskAdverse eventsQuality improvement effortsWatchman FLXAppendage occlusionFall riskLeft atrial appendage occlusion procedureRegistry dataImprovement effortsRisk of in-hospital major adverse eventsPredicting major adverse eventsLogistic regressionAdverse event ratesModerate discriminationClinically relevant variablesFemale sexAtrial fibrillation terminationLAAO procedures
2021
Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention
Castro-Dominguez YS, Wang Y, Minges KE, McNamara RL, Spertus JA, Dehmer GJ, Messenger JC, Lavin K, Anderson C, Blankinship K, Mercado N, Clary JM, Osborne AD, Curtis JP, Cavender MA. Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention. Journal Of The American College Of Cardiology 2021, 78: 216-229. PMID: 33957239, DOI: 10.1016/j.jacc.2021.04.067.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPercutaneous coronary interventionHospital mortalityQuality improvement effortsCoronary interventionDevelopment cohortValidation cohortRisk-standardized mortality ratesHospital risk-standardized mortality ratesBedside risk scoreHigh-risk patientsIn-Hospital MortalityHospital mortality riskRisk of mortalityLevel of consciousnessProcedural urgencyCathPCI RegistryClinical presentationRisk cohortRisk stratificationCardiovascular instabilityCardiac arrestMortality riskRisk scoreClinical acuityClinical relevanceDefibrillation Safety Margin Testing in Patients With Congenital Heart Disease Results From the NCDR
Prutkin JM, Wang Y, Escudero CA, Stephenson EA, Minges KE, Curtis JP, Hsu JC. Defibrillation Safety Margin Testing in Patients With Congenital Heart Disease Results From the NCDR. JACC Clinical Electrophysiology 2021, 7: 1145-1154. PMID: 33933411, DOI: 10.1016/j.jacep.2021.02.019.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCongenital heart diseaseLowest successful energyHospital stayNational Cardiovascular Data Registry ICD RegistryImplantable cardioverter-defibrillator insertionVentricular septal defectTetralogy of FallotHeart disease resultHospital complicationsHospital deathHospital outcomesMultivariable adjustmentEbstein's anomalyICD RegistryICD recipientsSeptal defectCommon ventricleHeart diseaseRetrospective analysisLower oddsGreat vesselsICD proceduresDisease resultsSuccessful energyICD generator
2020
Association Between Industry Payments to Physicians and Device Selection in ICD Implantation
Annapureddy AR, Henien S, Wang Y, Minges KE, Ross JS, Spatz ES, Desai NR, Peterson PN, Masoudi FA, Curtis JP. Association Between Industry Payments to Physicians and Device Selection in ICD Implantation. JAMA 2020, 324: 1755-1764. PMID: 33141208, PMCID: PMC7610190, DOI: 10.1001/jama.2020.17436.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCRT-D implantationCRT-D devicesCross-sectional studyNational Cardiovascular Data Registry ICD RegistryFirst-time ICDFirst-time implantationProportion of patientsEntire study cohortDevice selectionProportion of devicesICD implantationICD RegistryPrimary outcomeCardiac resynchronizationStudy cohortPatient groupMAIN OUTCOMEPatientsPhysiciansICDAbsolute differenceImplantationManufacturer CHigher total paymentsAssociationSurvival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
Higgins AY, Annapureddy AR, Wang Y, Minges KE, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV. Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy. Journal Of The American Heart Association 2020, 9: e016038. PMID: 32867553, PMCID: PMC7726970, DOI: 10.1161/jaha.120.016038.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsImplantable cardioverter defibrillator implantationCardioverter-defibrillator implantationNonischemic cardiomyopathyCardiac amyloidosisDiabetes mellitusCerebrovascular diseaseVentricular tachycardiaMultivariable Cox proportional hazards regression modelsCox proportional hazards regression modelProportional hazards regression modelsKaplan-Meier survival curvesCox proportional hazards modelPropensity-matched cohortOutcomes of patientsHazards regression modelsProportional hazards modelCause mortalityICD implantationRenal functionMultivariable analysisConclusions MortalityRisk factorsRegistry dataAmyloid cardiomyopathyHigh riskDuration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry)
Saad M, Tobolski J, Kolte D, Wang Y, Minges K, Hira RS, Curtis JP, Abbott JD. Duration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry). The American Journal Of Cardiology 2020, 133: 182-184. PMID: 32819682, DOI: 10.1016/j.amjcard.2020.07.029.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsComparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation
Higgins AY, Bjerre J, Parzynski CS, Minges KE, Ahmad T, Desai NR, Enriquez A, Spatz ES, Friedman DJ, Curtis JP, Hlatky MA, Freeman JV. Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation. The American Journal Of Cardiology 2020, 133: 116-125. PMID: 32862971, DOI: 10.1016/j.amjcard.2020.07.035.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsNon-ischemic cardiomyopathyImplantable cardioverter defibrillator implantationCardioverter-defibrillator implantationICM patientsIschemic cardiomyopathyNational Cardiovascular Data Registry ICD RegistryCox proportional hazards regression modelPrimary prevention ICD implantationLeft ventricular ejection fractionProportional hazards regression modelsPrimary prevention ICDsRetrospective cohort studyVentricular ejection fractionKaplan-Meier curvesHazards regression modelsRisk of mortalityComparison of mortalityMedian followCohort studyICD implantationEjection fractionHeart failureHospital readmissionICD RegistryPatient subgroups
News
News
Get In Touch
Contacts
Email